Literature DB >> 699976

Clozapine concentrations in brain regions: relationship to dopamine metabolite increase.

S Wilk, M Stanley.   

Abstract

Levels of clozapine in rat striatum and tuberculum olfactorium were quantitated by a gas chromatographic technique. The relationship of the increase in 3,4-dihydroxyphenylacetic acid (DOPAC) in these regions produced by clozapine to the concentration of clozapine was explored. One hour after 10, 20 or 40 mg/kg clozapine i.p. the concentration of drug increased in proportion to the dose and at each dose was similar in striatum and T.O. The percent increase in DOPAC in both areas was related to the clozapine concentration in a typical dose--response manner and was greater in the striatum than the T.O. A relatively high concentration of clozapine (40 micron) was required to produce a half-maximal elevation of DOPAC. Striatal clozapine levels were similar in acutely and chronically treated animals. The concentrations of clozapine in striatum and T.O. reflect the dose injected and do not account for its atypical properties.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699976     DOI: 10.1016/0014-2999(78)90334-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Seroquel: biochemical profile of a potential atypical antipsychotic.

Authors:  C F Saller; A I Salama
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Clozapine inhibition of metenkephalin binding to synaptosome-enriched fractions of rat whole brain and hippocampus.

Authors:  E Somoza; C Franco; M Laviña; J A Fuentes
Journal:  Neurochem Res       Date:  1981-04       Impact factor: 3.996

3.  Clozapine modulates retinoid homeostasis in human brain and normalizes serum retinoic acid deficit in patients with schizophrenia.

Authors:  Francesca Regen; Nicoleta-Carmen Cosma; Lisa R Otto; Vera Clemens; Lana Saksone; Janine Gellrich; Berk Uesekes; Thi Minh Tam Ta; Eric Hahn; Michael Dettling; Isabella Heuser; Julian Hellmann-Regen
Journal:  Mol Psychiatry       Date:  2020-06-02       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.